Presence of the HMOX1 L allele did not affect serum bilirubin concentrations, but as expected UGT1A1 (TA)7 gene variation significantly increased serum bilirubin concentrations in both NAFLD patients and controls (Table 2). This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.